当前位置:

网站首页>文章详情

类风湿关节炎合并冠心病患者的临床特点及预后分析

【PDF在线阅读】 【下载PDF】
  • Author:

  • Author Unit:

  • Keywords:

摘要:

目的 探讨类风湿性关节炎(RA)合并冠状动脉粥样硬化性心脏病(冠心病)患者的冠
状动脉(冠脉)病变特点及介入治疗后的长期预后。方法 连续入选2010年1月至2017年12月于郑州大
学附属洛阳市中心医院收治的RA合并冠心病的患者70例作为RA合并冠心病组,同时选取与其年龄和性
别匹配的冠心病患者140例作为冠心病组,均行冠脉造影检查。对两组的临床特点、冠脉病变特点及冠
脉介入治疗后的长期预后情况进行分析。结果 RA并冠心病组的体质指数、总胆固醇水平明显低于冠
心病组(P均<0.05)。冠脉造影结果中,RA合并冠心病组患者,GENSINI评分明显比冠心病组高(P
<0.05)。在长期随访中发现,RA并冠心病组患者的全因死亡率(5.9% vs. 1.5%,P<0.05)、心血管
相关死亡率(2.9% vs. 0.7%,P<0.05)、因ACS再次住院率(35.3% vs. 18.5%,P<0.05)、因急性心肌
梗死再次住院率(7.4% vs. 4.4%,P<0.05)均明显高于单纯冠心病组,再次血运重建率基本持平。结论
传统危险因素在RA患者动脉粥样硬化的发生中发挥了重要作用,但RA的病程也是导致动脉粥样硬化发
生的独立危险因素。且RA合并冠心病患者的冠脉血管病变范围及程度更重。RA并冠心病的预后较差。
其再次血运重建率与冠心病患者基本持平,或许提示了目前RA相关的心血管治疗的不足。

Abstract:

Objective To discuss the coronary lesion characteristics and long-term prognosis in patients with
rheumatoid arthritis complicated by coronary heart disease (RA-CHD) after interventional treatment. Methods The
patients with RA-CHD (n=70) were continuously chosen (RA-CHD group) from Central Hospital of Luoyang City
affiliated to Zhengzhou University from Jan. 2010 to Dec. 2017. At the same time, the patients with CHD (n=140,
matched in age and sex) were chosen (CHD group). All patients were given examination of coronary angiography (CAG).
The clinical characteristics, coronary lesion characteristics and long-term prognosis after interventional treatment
were analyzed in 2 groups. Results The levels of body mass index (BMI) and total cholesterol (TC) were significantly
lower in RA-CHD group than those in CHD group (all P<0.05). The results of CAG showed that GENSINI scores
were significantly higher in RA-CHD group than those in CHD group (P<0.05). The results of long-term follow-up
showed that all-cause mortality (5.9% vs. 1.5%, P<0.05), cardiovascular-related mortality (2.9% vs. 0.7%, P<0.05),
re-hospitalization rate due to acute coronary syndrome (35.3% vs. 18.5%, P<0.05), and re-hospitalization rate due to
acute myocardial infarction (7.4% vs. 4.4%, P<0.05) were significantly higher in RA-CHD group than those in CHD
group, and re-revascularization rate were basically the same in 2 groups. Conclusion Traditional risk factors play
a very important role in occurrence of atherosclerosis in RA patients, and RA course is an independent risk factor of
CHD. The range of coronary lesions will be larger and severity will be severer in patients with. The prognosis of RACHD
is poor. The re-revascularization rate were basically the same in patients with RA-CHD and in those with only
CHD, which may indicate the shortages in treatment of RA-related cardiovascular diseases.

基金项目:

洛阳心血管急救(5分钟)科技工程(1820002A)

参考文献:

[1] Hollan I,Meroni PL,Ahearn JM,et al. Cardiovascular disease in
autoimmune rheumatic diseases[J]. Autoimmun Rev,2013,12(10):
1004-15.
[2] Avi?a-Zubieta JA,Choi HK,Sadatsafavi M,et al. Risk of cardiovascular
mortality in patients with rheumatoid arthritis: a meta-analysis of
observational studies[J]. Arthritis Rheum,2008, 59(12):1690-7.
[3] Solomon DH,Karlson EW,Rimm EB,et al. Cardiovascular morbidity
and mortality in women diagnosed with rheumatoid arthritis[J]. Circul
ation,2003,107(9):1303-7.
[4] Libby P,Ridker PM,Hansson GK. Inflammation in atherosclerosis:
from pathophysiology to practice[J]. J Am Coll Cardiol,2009,54(23):
2129-38.
[5] Eagle KA,Guyton RA,Davidoff R,et al. ACC/AHA 2004 guideline
update for coronary artery bypass graft surgery: a report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee to Update the
1999 Guidelines for Coronary Artery Bypass Graft Surgery)[J].
Circulation,2004,110(14):e340-437.
[6] Marc AS,Christopher TS,Ted RM,et al. Repeat revascularisation
outcomes after percutaneous coronary intervention in patients with
rheumatoid arthritis[J]. Heart,2016,102(5):363-9.
[7] Amett FC,Edworthy SM,Bloch DA,et al. The American Rheumatism
Association 1987 revised criteria for the classification of rheumatoid
arthritis[J]. Arthritis Rheum,1988,31(3):315-24.
[8] Austen WG,Edwards JE,Fayo RL,et al. American heart association
report: a reporting system in patients evaluated for coronary artery
disease[J]. Circulation,1975,51(suppl):5-21.
[9] Gensini GG. A more meaningful scoring system for determining the
severity of coronary heart disease[J]. Am J Cardiol,1983,51(3):606.
[10] Wilson PW,Agostino RB,Levy D,et al. Prediction of coronary heart
disease using risk factor categories[J]. Circulation,1998,97(18):1837-47.
[11] Del Rincin ID,Williams K,Stem MP,et al. High Incidence of
Cardiovascular Events in a Rheumatoid Arthritis Cohort Not
Explained by Traditional Cardiac Risk Factors[J]. Arthritis Rheum,
2001,44(12):2737-45.
[ 1 2 ] E s c a l a n t e A , H a s RW. P a r a d o x i c a l E f f e c t o f B o d y M a s s
Index on Survival in RheumatoidArthritis[J]. Arch Intern
Med,2005,165(14):1624-9.
[13] Morton AC,Rothman AM,Greenwood JP,et al. The effect of
interleukin-1 receptor antagonist therapy on markers of inflammation
in non-ST elevation acute coronary syndromes:the MRC-ILA Heart
Study[J]. Eur Heart J,2015,36(6):377-84.
[14] Naranjo A,Sokka T,Descalzo MA,et al. Cardiovascular disease in
patients with rheumatoid arthritis:results from the QUEST-RA
study[J]. Arthritis Res Ther,2008,10(2):P.R30.
[15] Ku IA,Imboden JB,Hsue PY,et al. Rheumatoid arthritis:
model of systemic inflammation driving atherosclerosis[J]. Circ
J,2009,73(6):977-85.
[16] Warrington KJ,Kent PD,Frye RL,et al. Rheumatoid arthritis is an
independent risk factor for multi-vessel coronary artery disease:a
case control study[J]. Arthritis Res Ther,2005,7(5):R984-91.
  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com